Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 3-[(ethoxycarbonyl)amino]benzoate is a chemical compound with the molecular formula C12H15NO4. It is an organic ester derived from benzoic acid, featuring an ethyl group attached to the 3-position of the benzene ring, an amino group connected to the ethoxycarbonyl group, and an additional ethyl ester group. ethyl 3-[(ethoxycarbonyl)amino]benzoate is known for its potential applications in pharmaceuticals and agrochemicals, particularly as an intermediate in the synthesis of various drugs and pesticides. Its structure allows for the formation of various derivatives, making it a versatile building block in organic chemistry.

5100-22-1

Post Buying Request

5100-22-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5100-22-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5100-22-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,1,0 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5100-22:
(6*5)+(5*1)+(4*0)+(3*0)+(2*2)+(1*2)=41
41 % 10 = 1
So 5100-22-1 is a valid CAS Registry Number.

5100-22-1Relevant academic research and scientific papers

Design, Synthesis, and Herbicidal Evaluation of Novel Uracil Derivatives Containing 1,3,4-Thiadiazolyl Moiety

He, Lei-En,Wu, Ying-Ying,Zhang, Han-Yun,Liu, Man-Yun,Shi, De-Qing

, p. 1308 - 1313 (2015)

Uracil derivatives, such as commercial herbicides butafenacil and benzfendizone, have been identified as inhibitors of protoporphyrinogen oxidase (Protox, EC 1.3.3.4), one of the most important action targets of herbicides. In order to search for novel Pr

Novel Compounds as Autotaxin Inhibitors and Pharmaceutical Compositions Comprising the Same

-

Paragraph 0541-0542; 0555-0556; 0583-0586, (2018/05/17)

The present invention relates to a novel autotaxin inhibitor compound for preventing and treating disease or symptoms due to an increase in concentration of lysophosphatidic acid or activation of autotaxin. The present invention further relates to a pharmaceutical composition containing the same. The novel compound of the present invention is an autotaxin inhibitor which inhibits production of lysophosphatidic acid, and thus is useful for treating or preventing cardiovascular disease, cancer, metabolic disease, kidney disease, liver disease, inflammatory diseases, nervous disease, respiratory disease, desmoid disease, eye disease, cholestatic symptoms, other types of chronic pruritus or acute, or chronic rejection of transplanted organs.COPYRIGHT KIPO 2017

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5100-22-1